Outcomes of BCG Induction in High-Risk Non-Muscle-Invasive Bladder Cancer Patients (NMIBC): A Retrospective Cohort Study

Non-muscle-invasive bladder cancer (NMIBC) is categorized into high-risk and low-risk groups. Although, bacillus Calmette-Guerin (BCG) is the recommended adjuvant therapy of high-risk bladder tumor, optimal schedule (induction versus maintenance) of this therapy is a subject of debate. The objective...

Descripción completa

Detalles Bibliográficos
Autores principales: Pirzada, Muhammad T, Ghauri, Rashid, Ahmed, Monis J, Shah, Muhammad F, Nasir, Irfan ul Islam, Siddiqui, Jasim, Ahmed, Irfan, Mir, Khurram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291702/
https://www.ncbi.nlm.nih.gov/pubmed/28168135
http://dx.doi.org/10.7759/cureus.957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291702/
https://www.ncbi.nlm.nih.gov/pubmed/28168135
http://dx.doi.org/10.7759/cureus.957

Ejemplares similares